NYDRAZID
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Sep 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NYDRAZID is an injectable medication approved in 1952 as a legacy National Drug Application (NDA) product currently sponsored by Novartis. The specific indication, mechanism of action, and pharmacologic class are not documented in available data, limiting clinical context. The 70+ year approval history suggests this is an established, possibly off-patent therapeutic.
LOE Approaching
Product approaching loss of exclusivity with low competitive pressure (30%) signals a mature brand team likely focused on cost management and market defense rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings and LOE-approaching lifecycle indicate limited career momentum on this product; roles focus on sustaining profitability and managing transition to generic competition. Career development opportunities are constrained, making this assignment transitional rather than growth-oriented for most professionals.
Brand ManagerProduct Manager
Worked on NYDRAZID at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.